Refer A Patient

Request An Appointment

Rheumatology

ACTEMRA

ACTEMRA (tocilizumab) is a monoclonal antibody that helps the body’s immune system
Infusion or injection therapy referral
What it treats Rheumatoid Arthritis (RA),
Giant Cell Arteritis (GCA),
Polyarticular Juvenile Idiopathic Arthritis (JIA),
Systematic Juvenile Idiopathic Arthritis (JRA),
Cytokine Release Syndrome (CRS)
Prescribed by Rheumatologists
How it’s administered Most often given by intravenous (IV) infusion, but in some cases also by subcutaneous injection
Frequency Every four weeks for RA;
Once a week for GCA;
Every two, three, or four weeks for JIA
Length of treatment About one hour

About This Therapy

ACTEMRA (tocilizumab) is a monoclonal antibody that helps the body’s immune system by targeting and destroying certain cells, thereby helping to protect healthy cells from damage. Specifically, it is an interleukin-6 (IL-6) receptor antagonist used to treat various types of arthritis by reducing the effects of a substance in the body that can cause inflammation.

For more information, visit the patient website for this drug. Speak with your healthcare provider to learn if this drug is right for you.

ACTEMRA REFERRAL FORM

ACTEMRA REFERRAL FORM

Speak with your healthcare provider to learn if this therapy is right for you, then complete the referral form below.
REFERRAL FORM →

Ready to refer a patient for ACTEMRA

Our team handles benefits verification, prior authorization, and scheduling so you can focus on care.